Intuitive Surgical Reports Strong Preliminary Q4 and Full Year 2025 Results, Provides Positive 2026 Procedure Guidance

summarizeSummary

Intuitive Surgical announced strong preliminary Q4 and full year 2025 financial results, with significant revenue and da Vinci procedure growth, and provided positive guidance for 2026 da Vinci procedures.

check_boxKey Events

• Preliminary Q4 & FY 2025 Revenue Growth

  Intuitive Surgical reported preliminary Q4 2025 revenue of approximately $2.87 billion, a 19% increase year-over-year, and full year 2025 revenue of approximately $10.06 billion, up 21% from 2024.

• Strong Procedure Volume Growth

  Worldwide da Vinci and Ion procedures combined grew approximately 18% in Q4 2025 and 19% for the full year 2025. Da Vinci procedures alone increased by 17% in Q4 and 18% for the full year.

• Increased Da Vinci System Placements

  The company placed 532 da Vinci surgical systems in Q4 2025 (up from 493 in Q4 2024) and 1,721 systems for the full year 2025 (up from 1,526 in 2024), with a notable increase in da Vinci 5 system adoption.

• 2026 Procedure Guidance

  Intuitive Surgical expects worldwide da Vinci procedures to increase approximately 13% to 15% in 2026 compared to 2025.

auto_awesomeAnalysis

Intuitive Surgical's preliminary financial results for Q4 and full year 2025 demonstrate robust growth across key metrics, particularly in da Vinci procedures and revenue. The significant increase in da Vinci 5 system placements indicates strong adoption of its latest technology. While Ion system placements saw a decline, the overall strength of the da Vinci platform and positive procedure guidance for 2026 suggest continued momentum for the company. Investors should view these preliminary results and outlook as a strong indicator of the company's operational health and market position.